BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE2
GARDASILâ„¢ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Immunogenicity of a Booster Dose of Zoster Vaccine, Live (V211-029)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)
- Status
- COMPLETED
- Phase
- N/A
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
- Status
- TERMINATED
- Phase
- PHASE4
A Study of Two Methodologies for Measuring Blood Flow in the Brain in Response to Non-Drug Stimuli (P08085/MK-0000-180)
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Population Study on Candidemia in Spain
- Status
- COMPLETED
- Phase
- N/A
MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ridaforolimus (MK-8669) in Combination With Dalotuzumab (MK-0646) Compared to Standard of Care Treatment in Estrogen Receptor Positive Breast Cancer Patients (MK-8669-041 AM3)
- Status
- COMPLETED
- Phase
- PHASE2
Post-Exposure Prophylaxis in Health Care Workers
- Status
- COMPLETED
- Phase
- PHASE4
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
- Status
- COMPLETED
- Phase
- PHASE2
Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and Rhinitis
- Status
- UNKNOWN
- Phase
- N/A
The Relation Between Obesity, Adipose Tissue Content of Fatty Acids and Systemic and Airway Inflammation
- Status
- COMPLETED
- Phase
- N/A
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty
- Status
- COMPLETED
- Phase
- PHASE3